Back

SGLT2 inhibitors in heart failure with reduced ejection fraction without diabetes mellitus: why are patients outside the magic circle?

21 May 2023 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Heart failure with reduced ejection fraction (HFrEF) 2 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Daniela Santoro

A.O.U. Policlinico Consorziale Di Bari, Bari (Italy)

7 More presentations in this session

Presentation thumbnail
The usefulness of end-expiratory oxygen partial pressure as a prognostic indicator in patients with heart failure with reduced ejection fraction
Doctor T. Nakade (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Integrated transcriptomic and regulatory RNA sequencing and machine-learning driven analyses identify molecular signatures underlying human heart failure
Doctor J. Gulia (Bengaluru, IN)
Abstract Slides
Presentation thumbnail
Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac
Assistant Professor B. PARK (Daegu, KR)
Abstract Slides
Presentation thumbnail
Cardiac amyloidosis patients with reduced ejection fraction have an increase morbimortality
Doctor F. Bauer (Le Kremlin-Bicetre, FR)
Abstract Slides
Presentation thumbnail
Ivabradine improves survival in children with severe chronic heart failure
Doctor R. Adorisio (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with reduced ejection fraction (HFrEF) 2

The Event

Event poster

Heart Failure 2023

21 May 2023 13:00 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this.
29 August 2022
thumbnail
Congress Presentation
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
27 August 2021
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors on diastolic function in patients with non-obstructive hypertrophic cardiomyopathy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources